DILATATION OF SINOTUBULAR JUNCTION

This adverse event was reported 2 times

These drugs are most commonly taken by patients reporting DILATATION OF SINOTUBULAR JUNCTION:

# Drug Count
0 FENFLURAMINE 2
1 ACETAMINOPHEN 1
2 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 1
3 ALBUTEROL 1
4 ALBUTEROL SULFATE 1
5 ANTACID 1
6 CALCIUM CARBONATE 1
7 CANNABIDIOL 1
8 CLOBAZAM 1
9 DIAZEPAM 1
See all common drugs associated with DILATATION OF SINOTUBULAR JUNCTION

DILATATION OF SINOTUBULAR JUNCTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FENFLURAMINE 2 0.0004
1 LEVOCARNITINE 1 0.0003
2 GLYCOPYRROLATE 1 0.0002
3 CLOBAZAM 1 0.0001
4 SODIUM BICARBONATE INJECTION, 1 0.0000
5 CANNABIDIOL 1 0.0000
6 DIVALPROEX SODIUM 1 0.0000
7 CALCIUM CARBONATE 1 0.0000
8 FAMOTIDINE 1 0.0000
9 DIAZEPAM 1 0.0000
See all drugs enriched for association with DILATATION OF SINOTUBULAR JUNCTION

These drug classes are most commonly taken by patients reporting DILATATION OF SINOTUBULAR JUNCTION:

# Drug class Count
0 Benzodiazepine [EPC] 1
1 Carnitine Analog [EPC] 1
2 Expectorant [EPC] 1
3 Histamine-2 Receptor Antagonist [EPC] 1
See all common drug classes associated with DILATATION OF SINOTUBULAR JUNCTION

DILATATION OF SINOTUBULAR JUNCTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Carnitine Analog [EPC] 1 0.0003
1 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
2 Expectorant [EPC] 1 0.0000
3 Benzodiazepine [EPC] 1 0.0000
See all drug classes enriched for association with DILATATION OF SINOTUBULAR JUNCTION